22 hrs ago
AstraZeneca stocks respiratory and cancer pipelines
AstraZeneca has agreed to buy Spanish firm Almirall's respiratory drug assets for $875 million up front, plus up to $1.2 billion in performance milestone payments.
Strategic Respiratory Transaction with Almirall
ASTRAZENECA AGREES STRATEGIC TRANSACTION WITH ALMIRALL IN RESPIRATORY DISEASE Business combination will provide boost to revenue as well as creating long-term value, strengthening AstraZeneca's respiratory franchise with a complementary pipeline and inhaled device capabilities in asthma and COPD AstraZeneca today announced that it has entered an ... (more)
Elite Clinical Trials Test Doses of Dulera for Asthma
Elite Clinical Trials is in the works of testing different doses of Dulera in patients who have suffered from persistent asthma for more than one year.
Pharmacological similarities and differences between beta2-agonists.
Formoterol and salmeterol are both long-acting bronchodilators that are effective in the treatment of asthma.
Soma 250 mg, manufactured by Meda Pharmaceuticals Inc , is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.